(Q42991579)

12 November 2017

title

Cytotoxic capacity of hepatitis C virus (HCV)--specific lymphocytes after in vitro immunization with HCV-derived lipopeptides (English)

1 reference

12 November 2017

1 reference

Bettina Langhans

1

1 reference

12 November 2017

Susann Schweitzer

2

1 reference

12 November 2017

Ingrid Braunschweiger

3

1 reference

12 November 2017

Monika Schulz

4

1 reference

12 November 2017

Tilman Sauerbruch

5

1 reference

12 November 2017

Ulrich Spengler

6

1 reference

12 November 2017

language of work or name

1 reference

1 May 2005

1 reference

12 November 2017

1 reference

12 November 2017

volume

65

1 reference

12 November 2017

issue

1

1 reference

12 November 2017

page(s)

59-68

1 reference

Extension of HLA-A*0201-restricted minimal epitope by N epsilon-palmitoyl-lysine increases the life span of functional presentation to cytotoxic T cells

12 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

Toll-like receptor 2 ligands as adjuvants for human Th1 responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

Impaired effector function of hepatitis C virus-specific CD8+ T cells in chronic hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

The HLA-A2 restricted T cell epitope HCV core 35-44 stabilizes HLA-E expression and inhibits cytolysis mediated by natural killer cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

Regulation of IFN-gamma signaling is essential for the cytotoxic activity of CD8(+) T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

Cell mediated immune response to the hepatitis C virus.

21 January 2018

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Recurrence of hepatitis C virus after loss of virus-specific CD4(+) T-cell response in acute hepatitis C

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Role of the specific T-cell response for clearance and control of hepatitis C virus

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

CD8+ T lymphocyte responses are induced during acute hepatitis C virus infection but are not sustained

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Sustained Dysfunction of Antiviral CD8+ T Lymphocytes after Infection with Hepatitis C Virus

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

In vivo priming of virus-specific cytotoxic T lymphocytes with synthetic lipopeptide vaccine

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Two human immunodeficiency virus vaccinal lipopeptides follow different cross-presentation pathways in human dendritic cells.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Cell activation by synthetic lipopeptides of the hepatitis C virus (HCV)--core protein is mediated by toll like receptors (TLRs) 2 and 4.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Lipidation of T helper sequences from hepatitis C virus core significantly enhances T-cell activity in vitro

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Hepatitis C virus-derived lipopeptides differentially induce epitope-specific immune responses in vitro.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Primary immunisation of hepatitis C virus (HCV)-specific antibody producing B cells by lipidated peptides

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Flow cytometric analysis of peptide binding to major histocampatibility complex class I for hepatitis C virus core T-cell epitopes

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

A novel non-radioactive cellular cytotoxicity test based on the differential assessment of living and killed target and effector cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Natural cytotoxicity and antibody-dependent cellular cytotoxicity (ADCC) is not impaired in patients suffering from chronic hepatitis C.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Genes regulating HLA class I antigen expression in T-B lymphoblast hybrids.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Visualization and quantification of T cell-mediated cytotoxicity using cell-permeable fluorogenic caspase substrates

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Serial killing by cytotoxic T lymphocytes: T cell receptor triggers degranulation, re-filling of the lytic granules and secretion of lytic proteins via a non-granule pathway

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Antigen presentation and T cell stimulation by dendritic cells

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Viral immune evasion due to persistence of activated T cells without effector function

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Characterization of circulating T cells specific for tumor-associated antigens in melanoma patients

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

HIV-specific CD8(+) T cells produce antiviral cytokines but are impaired in cytolytic function

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Oral immunization with HCV-NS3-transformed Salmonella: induction of HCV-specific CTL in a transgenic mouse model

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Incomplete CD8(+) T lymphocyte differentiation as a mechanism for subdominant cytotoxic T lymphocyte responses to a viral antigen

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Partial activation of CD8+ T cells by a self-derived peptide

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Lymphocyte-mediated cytotoxicity.

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Viral and immunological determinants of hepatitis C virus clearance, persistence, and disease

1 reference

https://api.crossref.org/works/10.1002%2FCYTO.A.20136

7 January 2021

Identifiers

DOI

10.1002/CYTO.A.20136

1 reference

12 November 2017

1 reference